Wedbush Maintains Outperform on Imax, Raises Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Alicia Reese maintains an Outperform rating on Imax (NYSE:IMAX) and raises the price target from $22 to $24.
July 26, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Alicia Reese has maintained an Outperform rating on Imax and increased the price target from $22 to $24, indicating confidence in the company's future performance.
The increase in the price target from $22 to $24 by a reputable analyst suggests a positive outlook for Imax's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100